Davis's Insider Trades & SAST Disclosures
Davis's most recent trade in Hancock Whitney Corp. was a trade of 2,239 Common Stock done at an average price of $57.3 . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Davis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hancock Whitney Corp. | Stacy Jo Davis | Chief HR Officer | Grant, award, or other acquisition of securities at price $ 57.32 per share. | 15 May 2025 | 2,239 | 2,239 (0%) | 0% | 57.3 | 128,339 | Common Stock |
| United Community Banks Inc | Sally Pope Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 2,526 | 5,790 (0%) | 0% | 0 | Common Stock | |
| Dutch Bros Inc - Ordinary ... | Thomas J. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 1,779 | 1,779 | - | - | Restricted Stock Units | |
| Tile Shop Hldgs Inc | Mark Burton Davis | Senior VP, CFO and Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 1,478 | 128,111 (0%) | 0% | 0 | Common Stock | |
| RLI Corp. | Seth A. Davis | VICE PRESIDENT, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 1,250 | 1,250 | - | - | Stock Option | |
| Dutch Bros Inc - Ordinary ... | Thomas J. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 763 | 0 | - | - | Restricted Stock Units | |
| Dutch Bros Inc - Ordinary ... | Thomas J. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 763 | 12,342 | - | 0 | Class A Common Stock | |
| Tile Shop Hldgs Inc | Mark Burton Davis | Senior VP, CFO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.26 per share. | 13 May 2025 | 296 | 127,815 (0%) | 0% | 6.3 | 1,853 | Common Stock |
| RLI Corp. | Seth A. Davis | VICE PRESIDENT, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 250 | 250 | - | - | Restricted Stock Unit | |
| Steven Madden Ltd. | Peter A. Davis | Director | Sale of securities on an exchange or to another person at price $ 26.13 per share. | 12 May 2025 | 2,200 | 4,624 (0%) | 0% | 26.1 | 57,489 | Common Stock, par value $0.0001 per share |
| Grace Therapeutics Inc. | A. Brian Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Ligand Pharmaceuticals, In... | Todd C. Davis | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 105.67 per share. | 09 May 2025 | 5,523 | 161,234 (0%) | 0% | 105.7 | 583,629 | Common Stock |
| Edwards Lifesciences Corp | Leslie C. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 3,528 | 6,583 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharmaceuticals, In... | Todd C. Davis | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 104.53 per share. | 09 May 2025 | 2,307 | 155,711 (0%) | 0% | 104.5 | 241,150 | Common Stock |
| Ligand Pharmaceuticals, In... | Todd C. Davis | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 104.57 per share. | 09 May 2025 | 1,680 | 153,404 (0%) | 0% | 104.6 | 175,678 | Common Stock |
| Progressive Corp. | Charles A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,248 | 337,977 (0%) | 0% | 0 | Common | |
| Abbvie Inc | Jennifer L. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,203 | 2,525 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Turning Point Brands Inc | Ashley Davis Frushone | Director | Grant, award, or other acquisition of securities at price $ 75.66 per share. | 08 May 2025 | 1,058 | 7,499 (0%) | 0% | 75.7 | 80,048 | Common Stock |
| Brinker International, Inc. | Cynthia L. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 256 | 11,581 (0%) | 0% | 0 | Common Stock | |
| United States Steel Corp. | Alicia J. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 3,873 | 17,948 (0%) | 0% | 0 | United States Steel Corporation Common Stock | |
| Oshkosh Corp | Douglas L. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,927 | 7,672 (0%) | 0% | 0 | Common Stock | |
| Manitowoc Co., Inc. | Amy Rochelle Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 18,601 | 45,448 (0%) | 0% | 0 | Common Stock | |
| Kirby Corp. | Barry E. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 1,923 | 35,723 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
| RLI Corp. | Seth A. Davis | VICE PRESIDENT, CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 300 | 26,674 (0%) | 0% | 0 | Common Stock | |
| RLI Corp. | Seth A. Davis | VICE PRESIDENT, CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 300 | 0 | - | - | Restricted Stock Unit | |
| RLI Corp. | Seth A. Davis | VICE PRESIDENT, CONTROLLER | Other type of transaction at price $ 0.00 per share. | 05 May 2025 | 36 | 26,710 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Ivanetta Davis Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2025 | 1,690 | 7,600 (0%) | 0% | 0 | Common Stock | |
| Triumph Financial Inc | Davis R Deadman | Director | Purchase of securities on an exchange or from another person at price $ 21.70 per share. | 02 May 2025 | 601 | 26,101 (0%) | 0% | 21.7 | 13,042 | Depository Shares |
| Triumph Financial Inc | Davis R Deadman | Director | Purchase of securities on an exchange or from another person at price $ 21.50 per share. | 02 May 2025 | 399 | 26,500 (0%) | 0% | 21.5 | 8,579 | Depository Shares |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 7.66 per share. | 02 May 2025 | 123 | 80,760 (0%) | 0% | 7.7 | 942 | Common Stock |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 8.14 per share. | 02 May 2025 | 108 | 80,636 (0%) | 0% | 8.1 | 879 | Common Stock |
| Americas Car Mart, Inc. | Julia K. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 3,135 | 5,581 (0%) | 0% | 0 | Common Stock | |
| Duke Energy Corp. | Robert M. Davis | Director | Grant, award, or other acquisition of securities at price $ 121.33 per share. | 01 May 2025 | 1,607 | 12,660 (0%) | 0% | 121.3 | 194,977 | Common Stock |
| SouthState Corporation | Davis Martin B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 1,136 | 1,136 | - | - | Restricted Share Units | |
| Adeia Inc | Paul E. Davis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 129,186 | 1,024,469 (2%) | 0% | 0 | Common Stock | |
| Adeia Inc | Paul E. Davis | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.31 per share. | 30 Apr 2025 | 65,596 | 958,873 (1%) | 0% | 12.3 | 807,487 | Common Stock |
| William Penn Bancorporation | Glenn Davis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 34,760 | 0 | - | - | Stock Option (right to buy) | |
| William Penn Bancorporation | Glenn Davis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 31,341 | 0 | - | 0 | Common Stock | |
| William Penn Bancorporation | Glenn Davis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 20,944 | 0 | - | 0 | Common Stock | |
| William Penn Bancorporation | Glenn Davis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 9,480 | 0 | - | - | Stock Option (right to buy) | |
| William Penn Bancorporation | Glenn Davis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 8,343 | 0 | - | 0 | Common Stock | |
| William Penn Bancorporation | Glenn Davis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 3,034 | 0 | - | 0 | Common Stock | |
| W.W. Grainger Inc. | George Davis S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 178 | 788 | - | - | Deferred Stock Units | |
| W.W. Grainger Inc. | George S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 143 | 931 | - | - | Deferred Stock Units | |
| United States Steel Corp. | Alicia J. Davis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.13 per share. | 30 Apr 2025 | 47 | 14,075 (0%) | 0% | 43.1 | 2,027 | United States Steel Corporation Common Stock |
| Merck & Co Inc | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 181,623 | 181,623 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 39,901 | 39,901 | - | - | Restricted Stock Unit | |
| Wells Fargo & Co. | Richard K. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 3,728 | 14,108 | - | - | Common Stock Units | |
| First Financial Bankshares... | Sally Pope Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 2,073 | 5,271 (0%) | 0% | 0 | Common Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 161.38 per share. | 29 Apr 2025 | 1,000 | 51,964 (0%) | 0% | 161.4 | 161,384 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 22 | 179 | - | - | Restricted Stock Units | |
| RLJ Lodging Trust | Nathaniel A. Davis | Director | Grant, award, or other acquisition of securities at price $ 7.02 per share. | 25 Apr 2025 | 18,518 | 73,652 (0%) | 0% | 7.0 | 129,996 | Common Stock |
| Triumph Financial Inc | Davis R Deadman | Director | Purchase of securities on an exchange or from another person at price $ 53.50 per share. | 25 Apr 2025 | 1,500 | 10,220 (0%) | 0% | 53.5 | 80,250 | Common Stock |
| Sangamo Therapeutics Inc | Gregory D. Davis | Head of Research & Technology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.78 per share. | 22 Apr 2025 | 6,708 | 209,376 (0%) | 0% | 0.8 | 5,207 | Common Stock |
| Regions Financial Corp. | Noopur Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 7,595 | 7,595 | - | - | Restricted Stock Units | |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 5.51 per share. | 17 Apr 2025 | 171 | 80,528 (0%) | 0% | 5.5 | 942 | Common Stock |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 5.86 per share. | 17 Apr 2025 | 150 | 80,356 (0%) | 0% | 5.9 | 879 | Common Stock |
| Regions Financial Corp. | Noopur Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2025 | 7,089 | 20,463 (0%) | 0% | 0 | Common Stock | |
| Regions Financial Corp. | Noopur Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2025 | 7,089 | 0 | - | - | Restricted Stock Units | |
| Honeywell International Inc | D. Scott Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 650 | 0 | - | - | Restricted Stock Units | |
| Honeywell International Inc | D. Scott Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 200.38 per share. | 15 Apr 2025 | 650 | 30,229 (0%) | 0% | 200.4 | 130,247 | Common Stock |
| WSFS Financial Corp. | Christine E. Davis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.26 per share. | 15 Apr 2025 | 266 | 9,941 (0%) | 0% | 47.3 | 12,571 | Common Stock |
| WSFS Financial Corp. | Christine E. Davis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.26 per share. | 15 Apr 2025 | 209 | 9,678 (0%) | 0% | 47.3 | 9,877 | Common Stock |
| WSFS Financial Corp. | Christine E. Davis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.26 per share. | 15 Apr 2025 | 202 | 10,207 (0%) | 0% | 47.3 | 9,547 | Common Stock |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 5.68 per share. | 15 Apr 2025 | 122 | 80,180 (0%) | 0% | 5.7 | 693 | Common Stock |
| WSFS Financial Corp. | Christine E. Davis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.26 per share. | 15 Apr 2025 | 54 | 9,887 (0%) | 0% | 47.3 | 2,552 | Common Stock |
| WSFS Financial Corp. | Christine E. Davis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.25 per share. | 15 Apr 2025 | 40 | 10,409 (0%) | 0% | 47.3 | 1,890 | Common Stock |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 5.48 per share. | 15 Apr 2025 | 25 | 80,205 (0%) | 0% | 5.5 | 137 | Common Stock |
| Franklin Electric Co., Inc. | Delancey W. Davis | President, Headwater Companies | Grant, award, or other acquisition of securities at price $ 89.13 per share. | 14 Apr 2025 | 2,178 | 9,879 (0%) | 0% | 89.1 | 194,125 | common stock |
| Franklin Electric Co., Inc. | Delancey W. Davis | President, Headwater Companies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.13 per share. | 14 Apr 2025 | 910 | 8,969 (0%) | 0% | 89.1 | 81,108 | common stock |
| Designer Brands Inc - Ordi... | Laura T. Davis | EVP;Pres DSW Designer ShoeWhse | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 6,158 | 12,327 | - | - | Dividend Equivalent Rights | |
| Progressive Corp. | Charles A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 7 | 19,394 | - | - | Phantom Stock Unit (rest. Stock) | |
| Progressive Corp. | Charles A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 1 | 4,729 | - | - | Phantom Stock Units | |
| Dixie Group Inc. | W. Derek Davis | VP Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 10 Apr 2025 | 7,911 | 195,021 (1%) | 0% | 0.4 | 3,402 | Common Stock, $3 par value |
| Dow Inc | Richard K. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 7,146 | 50,172 (0%) | 0% | 0 | Common Stock | |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 5.78 per share. | 04 Apr 2025 | 163 | 80,058 (0%) | 0% | 5.8 | 942 | Common Stock |
| Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 6.15 per share. | 04 Apr 2025 | 143 | 79,894 (0%) | 0% | 6.1 | 879 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 167.86 per share. | 02 Apr 2025 | 7,249 | 155,084 (0%) | 0% | 167.9 | 1,216,845 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 167.86 per share. | 02 Apr 2025 | 6,950 | 140,465 (0%) | 0% | 167.9 | 1,166,627 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 168.66 per share. | 02 Apr 2025 | 5,900 | 134,565 (0%) | 0% | 168.7 | 995,121 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 168.72 per share. | 02 Apr 2025 | 4,905 | 150,179 (0%) | 0% | 168.7 | 827,564 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 169.56 per share. | 02 Apr 2025 | 2,764 | 147,415 (0%) | 0% | 169.6 | 468,662 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 169.57 per share. | 02 Apr 2025 | 2,493 | 132,072 (0%) | 0% | 169.6 | 422,736 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 168.03 per share. | 02 Apr 2025 | 2,366 | 164,448 (0%) | 0% | 168.0 | 397,553 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 167.88 per share. | 02 Apr 2025 | 1,493 | 128,978 (0%) | 0% | 167.9 | 250,643 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 168.76 per share. | 02 Apr 2025 | 1,411 | 163,037 (0%) | 0% | 168.8 | 238,114 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 168.79 per share. | 02 Apr 2025 | 902 | 128,076 (0%) | 0% | 168.8 | 152,249 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 167.86 per share. | 02 Apr 2025 | 750 | 131,322 (0%) | 0% | 167.9 | 125,897 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 169.62 per share. | 02 Apr 2025 | 704 | 162,333 (0%) | 0% | 169.6 | 119,416 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 168.70 per share. | 02 Apr 2025 | 584 | 130,738 (0%) | 0% | 168.7 | 98,520 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 169.63 per share. | 02 Apr 2025 | 453 | 127,623 (0%) | 0% | 169.6 | 76,844 | Common Stock |
| Quest Diagnostics, Inc. | James E. Davis | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 169.60 per share. | 02 Apr 2025 | 267 | 130,471 (0%) | 0% | 169.6 | 45,282 | Common Stock |
| Sypris Solutions, Inc. | Richard L. Davis | SVP and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.65 per share. | 01 Apr 2025 | 8,960 | 279,228 (1%) | 0% | 1.7 | 14,784 | Common Stock |
| Coca-Cola Co | Christopher C. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 4,332 | 44,789 | - | - | Phantom Share Units | |
| Genesis Energy L.P. - Unit | James E. Davison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,643 | 2,720,533 (2%) | 0% | - | Common Units - Class A | |
| Genesis Energy L.P. - Unit | James E. Davison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,643 | 8,917 | - | - | Phantom Units | |
| Genesis Energy L.P. - Unit | James E. Davison | Director | Sale or transfer of securities back to the company at price $ 14.35 per share. | 01 Apr 2025 | 2,643 | 2,717,890 (2%) | 0% | 14.3 | 37,927 | Common Units - Class A |
| Genesis Energy L.P. - Unit | James E. Davison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,643 | 3,885,688 (3%) | 0% | - | Common Units - Class A | |
| Genesis Energy L.P. - Unit | James E. Davison | Director | Sale or transfer of securities back to the company at price $ 14.35 per share. | 01 Apr 2025 | 2,643 | 3,883,045 (3%) | 0% | 14.3 | 37,927 | Common Units - Class A |
| Genesis Energy L.P. - Unit | James E. Davison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,643 | 8,917 | - | - | Phantom Units | |
| Priority Technology Holdin... | Marietta C. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,436 | 7,311 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges